GLP-1 receptor agonists

R&D

GLP-1 RA medicine has transformed treatment of metabolic diseases such as obesity and diabetes. We spoke with China's CORXEL about theirs.

News

Enhertu plus Perjeta has become the first new frontline therapy approved for advanced HER2-positive breast cancer in the EU for over a decade.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.